"I am pleased to lead ACRO at a time when our industry is exerting its voice on important policy matters in the U.S., Europe and globally while also strengthening our relationships with research sponsors and sites," said Jamie Macdonald, 2015 ACRO Chairman. "We see further opportunities in the year ahead to build deeper connections into the research site and patient communities."
Macdonald highlighted some of ACRO's 2014 accomplishments, including: advocating to expand the U.S. Research & Development tax credit to CROs; active participation in the 21st Century Cures initiative; strongly representing CRO interests in the implementation of the European Clinical Trials Regulation; the formation of the CRO Forum to interact with TransCelerate Biopharma Inc.; and conducting research illustrating the growth and expertise of the CRO industry.
"ACRO members represent more than two-thirds of contract biopharmaceutical research activity globally and we expect to further increase our membership this year as more CROs see the value of active participation in the association," said ACRO Executive Director Doug Peddicord, Ph.D. "ACRO will continue to advocate for sound regulatory and economic policies that encourage innovation in clinical research."
ACRO also elected as officers: Judd Hartman, General Counsel of PPD, as Secretary; and Christopher Gaenzle, Chief Administrative Officer and General Counsel of INC Research, as Treasurer.
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 100,000 professionals worldwide and conduct research in 142 countries. For more information, please visit www.acrohealth.org. Twitter@acrohealth. YouTube @ACROHealthChannel. Facebook. RebelMouse.